Loading...
XASXHCT
Market cap1mUSD
Dec 20, Last price  
0.01AUD
1D
25.00%
1Q
-50.00%
Name

Holista CollTech Ltd

Chart & Performance

D1W1MN
XASX:HCT chart
P/E
—
P/S
0.48
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
6.17%
Rev. gr., 5y
-5.86%
Revenues
6m
-27.84%
21,1141,00028,17037,5539,2006,250,0006,077,0005,440,0005,199,0056,178,4047,060,2806,263,6718,008,3887,846,8818,042,7977,257,7787,106,6358,023,1298,241,2255,946,909
Net income
-5m
L+230.77%
-1,525,900-2,087,921-2,788,392-1,884,598-1,919,671-1,573,000-804,000-536,000-1,600,700-3,280,82233,488-407,930332,536-3,030,290-1,612,147-689,851-5,483,167-1,256,209-1,452,902-4,805,763
CFO
-407k
L-63.37%
00000-1,981,000-79,000-265,815-328,145-276,092-4,233394,7441,378,416240,922-2,200,266-160,975-3,867,610-1,676,068-1,111,444-407,121
Earnings
Jan 29, 2025

Profile

Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; and healthy food ingredients, including low-glycaemic index (GI) flour mix for noodles, pasta, flatbreads and other baked products, low-sodium salt, low-fat fried foods, less-calorie sugar, and low-GI sugar. The company also provides infection control solutions. Holista CollTech Limited is based in Subiaco, Australia.
URL
https://www.holistaco.com/
IPO date
Feb 26, 2004
Employees
3
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122016‑062015‑06
Income
Revenues
5,947
-27.84%
8,241
2.72%
8,023
12.90%
Cost of revenue
6,771
9,101
8,789
Unusual Expense (Income)
NOPBT
(824)
(860)
(766)
NOPBT Margin
Operating Taxes
65
157
153
Tax Rate
NOPAT
(889)
(1,017)
(919)
Net income
(4,806)
230.77%
(1,453)
15.66%
(1,256)
-77.09%
Dividends
Dividend yield
Proceeds from repurchase of equity
1
80
BB yield
-1.00%
Debt
Debt current
962
520
378
Long-term debt
835
700
512
Deferred revenue
242
Other long-term liabilities
334
334
369
Net debt
1,737
(236)
(1,581)
Cash flow
Cash from operating activities
(407)
(1,111)
(1,676)
CAPEX
(5)
(77)
(41)
Cash from investing activities
(47)
(106)
50
Cash from financing activities
418
121
109
FCF
3,488
(1,126)
(716)
Balance
Cash
60
118
1,213
Long term investments
1,339
1,258
Excess cash
1,044
2,070
Stockholders' equity
(3,386)
1,557
2,976
Invested Capital
1,901
2,066
2,072
ROIC
ROCE
55.49%
EV
Common stock shares outstanding
278,800
276,821
275,349
Price
0.03
-38.30%
0.05
-34.72%
Market cap
8,028
-37.97%
12,941
-33.14%
EV
6,519
10,239
EBITDA
(584)
(586)
(566)
EV/EBITDA
Interest
91
67
47
Interest/NOPBT